LEOPOLD, Valentine, Etienne GAYAT, Romain PIRRACCHIO, Jindřich ŠPINAR, Jiří PAŘENICA, Tuukka TARVASMAKI, Johan LASSUS, Veli-Pekka HARJOLA, Sebastien CHAMPION, Faiez ZANNAD, Serafina VALENTE, Philip URBAN, Horng-Ruey CHUA, Rinaldo BELLOMO, Batric POPOVIC, Dagmar M. OUWENEEL, Jose P. S. HENRIQUES, Gregor SIMONIS, Bruno LEVY, Antoine KIMMOUN, Philippe GAUDARD, Mir Babar BASIR, Andrej MARKOTA, Christoph ADLER, Hannes REUTER, Alexandre MEBAZAA and Tahar CHOUIHED. Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients. Intensive care medicine. NEW YORK: SPRINGER, 2018, vol. 44, No 6, p. 847-856. ISSN 0342-4642. Available from: https://dx.doi.org/10.1007/s00134-018-5222-9.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients
Authors LEOPOLD, Valentine (250 France), Etienne GAYAT (250 France), Romain PIRRACCHIO (250 France), Jindřich ŠPINAR (203 Czech Republic, belonging to the institution), Jiří PAŘENICA (203 Czech Republic, belonging to the institution), Tuukka TARVASMAKI (246 Finland), Johan LASSUS (246 Finland), Veli-Pekka HARJOLA (246 Finland), Sebastien CHAMPION (250 France), Faiez ZANNAD (250 France), Serafina VALENTE (380 Italy), Philip URBAN (756 Switzerland), Horng-Ruey CHUA (36 Australia), Rinaldo BELLOMO (36 Australia), Batric POPOVIC (250 France), Dagmar M. OUWENEEL (528 Netherlands), Jose P. S. HENRIQUES (528 Netherlands), Gregor SIMONIS (276 Germany), Bruno LEVY (250 France), Antoine KIMMOUN (250 France), Philippe GAUDARD (250 France), Mir Babar BASIR (840 United States of America), Andrej MARKOTA (705 Slovenia), Christoph ADLER (276 Germany), Hannes REUTER (276 Germany), Alexandre MEBAZAA (250 France, guarantor) and Tahar CHOUIHED (250 France).
Edition Intensive care medicine, NEW YORK, SPRINGER, 2018, 0342-4642.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 18.967
RIV identification code RIV/00216224:14110/18:00104160
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1007/s00134-018-5222-9
UT WoS 000435995400012
Keywords in English Meta-analysis; Cardiogenic shock; Epinephrine; Prognosis
Tags 14110211, rivok
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 9/2/2019 22:48.
Abstract
Catecholamines have been the mainstay of pharmacological treatment of cardiogenic shock (CS). Recently, use of epinephrine has been associated with detrimental outcomes. In the present study we aimed to evaluate the association between epinephrine use and short-term mortality in all-cause CS patients. We performed a meta-analysis of individual data with prespecified inclusion criteria: (1) patients in non-surgical CS treated with inotropes and/or vasopressors and (2) at least 15% of patients treated with epinephrine administrated alone or in association with other inotropes/vasopressors. The primary outcome was short-term mortality. Fourteen published cohorts and two unpublished data sets were included. We studied 2583 patients. Across all cohorts of patients, the incidence of epinephrine use was 37% (17-76%) and short-term mortality rate was 49% (21-69%). A positive correlation was found between percentages of epinephrine use and short-term mortality in the CS cohort. The risk of death was higher in epinephrine-treated CS patients (OR [CI] = 3.3 [2.8-3.9]) compared to patients treated with other drug regimens. Adjusted mortality risk remained striking in epinephrine-treated patients (n = 1227) (adjusted OR = 4.7 [3.4-6.4]). After propensity score matching, two sets of 338 matched patients were identified and epinephrine use remained associated with a strong detrimental impact on short-term mortality (OR = 4.2 [3.0-6.0]). In this very large cohort, epinephrine use for hemodynamic management of CS patients is associated with a threefold increase of risk of death.
PrintDisplayed: 4/5/2024 10:32